1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Individual Investigator Research Awards for Cancer in Children and Adolescents (IIRACCA) is sponsored by Cancer Prevention and Research Institute of Texas (CPRIT). Supports applications for innovative research projects addressing questions that will advance knowledge of the causes, prevention, progression, detection, or treatment of cancer in children and adolescents. Laboratory, clinical, or population-based studies are all acceptable.
CPRIT expects the outcome of the research to reduce the incidence, morbidity, or mortality from cancer in children and/or adolescents in the near- or long-term.
Get alerted about grants like this
Save a search for “Cancer Prevention and Research Institute of Texas (CPRIT)” or related topics and get emailed when new opportunities appear.
Search similar grants →Based on current listing details, eligibility includes: Eligible institutions. Provides support to recruit or retain experienced clinical trialists, e.g., oncologists in any specialty, to lead cancer clinical research programs in rural and underserved communities in the State of Texas. Funding may be used for the recruitment of qualified investigators at the level of early-career, mid-career, and established oncologists, e.g., Assistant Professor, Associate Professor, or Professor. Applicants should confirm final requirements in the official notice before submission.
Current published award information indicates See official notice Always verify allowable costs, matching requirements, and funding caps directly in the sponsor documentation.
The current target date is rolling deadlines or periodic funding windows. Build your timeline backwards from this date to cover registrations, approvals, attachments, and final submission checks.
Federal grant success rates typically range from 10-30%, varying by agency and program. Build a strong proposal with clear objectives, measurable outcomes, and a well-justified budget to improve your chances.
Requirements vary by sponsor, but typically include a project narrative, budget justification, organizational capability statement, and key personnel CVs. Check the official notice for the complete list of required attachments.
Yes — AI tools like Granted can help research funders, draft proposal sections, and check compliance. However, always review and customize AI-generated content to reflect your organization's unique strengths and the specific requirements of the solicitation.
Review timelines vary by funder. Federal agencies typically take 3-6 months from submission to award notification. Foundation grants may be faster, often 1-3 months. Check the program's timeline in the official solicitation for specific dates.
Many federal programs offer multi-year funding or allow competitive renewals. Check the official solicitation for continuation and renewal policies. Non-competing continuation applications are common for multi-year awards.
Past winners and funding trends for this program
Individual Investigator Research Awards for Clinical Trials (IIRACT) is a grant from the Cancer Prevention and Research Institute of Texas (CPRIT) that funds clinical trials research aimed at preventing and curing cancer in Texas. The program supports Texas-based entities conducting clinical trials across cancer types, with applications accepted through May 20, 2026 (RRCTA mechanism) and with an April 28, 2026 deadline for individual investigator awards. Eligible applicants include nonprofit institutions and private companies based in Texas. CPRIT now supports ORCID IDs in applicant profiles to streamline the application process.
CPRIT Seed Company Award (RFA C-26.1-SEED) is a grant from the Cancer Prevention and Research Institute of Texas (CPRIT) that funds early-stage Texas-based companies developing cancer prevention or research products. The Seed Award supports product development research — including therapeutics, diagnostics, and new technologies — for companies at the pre-commercialization stage looking to advance their cancer-related innovations toward market readiness. CPRIT's product development grants are designed to catalyze commercial investment and keep cancer-focused companies growing within Texas. Eligible applicants are Texas-based for-profit companies, or companies willing to relocate to Texas. Awards are available up to ,000,000. The deadline for preliminary applications is April 16, 2026, with full applications due June 10, 2026.